APA

Thacker S. G., McWilliams I. L., Bonnet B., Halie L., Beaucage S., Rachuri S., Dey R., Duncan R., Modabber F., Robinson S., Bilbe G., Arana B. & Verthelyi D. (20200427). CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. : PLoS neglected tropical diseases.

Chicago

Thacker Seth G, McWilliams Ian L, Bonnet Beatrice, Halie Lydia, Beaucage Serge, Rachuri Swaksha, Dey Ranadhir, Duncan Robert, Modabber Farrokh, Robinson Stephen, Bilbe Graeme, Arana Byron and Verthelyi Daniela. 20200427. CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. : PLoS neglected tropical diseases.

Harvard

Thacker S. G., McWilliams I. L., Bonnet B., Halie L., Beaucage S., Rachuri S., Dey R., Duncan R., Modabber F., Robinson S., Bilbe G., Arana B. and Verthelyi D. (20200427). CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. : PLoS neglected tropical diseases.

MLA

Thacker Seth G, McWilliams Ian L, Bonnet Beatrice, Halie Lydia, Beaucage Serge, Rachuri Swaksha, Dey Ranadhir, Duncan Robert, Modabber Farrokh, Robinson Stephen, Bilbe Graeme, Arana Byron and Verthelyi Daniela. CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. : PLoS neglected tropical diseases. 20200427.